BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 24809332)

  • 21. Renal perfusion 3-T MR imaging: a comparative study of arterial spin labeling and dynamic contrast-enhanced techniques.
    Wu WC; Su MY; Chang CC; Tseng WY; Liu KL
    Radiology; 2011 Dec; 261(3):845-53. PubMed ID: 22095996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CT.
    Korporaal JG; van den Berg CA; van Osch MJ; Groenendaal G; van Vulpen M; van der Heide UA
    Magn Reson Med; 2011 Nov; 66(5):1267-74. PubMed ID: 21604291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome.
    Ritt M; Janka R; Schneider MP; Martirosian P; Hornegger J; Bautz W; Uder M; Schmieder RE
    Nephrol Dial Transplant; 2010 Apr; 25(4):1126-33. PubMed ID: 19934080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of renal perfusion: comparison of arterial spin labeling and dynamic contrast-enhanced MRI.
    Winter JD; St Lawrence KS; Cheng HL
    J Magn Reson Imaging; 2011 Sep; 34(3):608-15. PubMed ID: 21761490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study.
    Turco S; Lavini C; Heijmink S; Barentsz J; Wijkstra H; Mischi M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W242-W251. PubMed ID: 30346837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
    Ziayee F; Müller-Lutz A; Gross J; Quentin M; Ullrich T; Heusch P; Arsov C; Rabenalt R; Albers P; Antoch G; Wittsack HJ; Schimmöller L
    Magn Reson Imaging; 2018 Nov; 53():28-33. PubMed ID: 29902565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of prostate cancer from normal prostate tissue: role of hotspots in pharmacokinetic MRI and histologic evaluation.
    Franiel T; Lüdemann L; Rudolph B; Lutterbeck E; Hamm B; Beyersdorff D
    AJR Am J Roentgenol; 2010 Mar; 194(3):675-81. PubMed ID: 20173144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal plasma flow (RPF) measured with multiple-inversion-time arterial spin labeling (ASL) and tracer kinetic analysis: Validation against a dynamic contrast-enhancement method.
    Conlin CC; Oesingmann N; Bolster B; Huang Y; Lee VS; Zhang JL
    Magn Reson Imaging; 2017 Apr; 37():51-55. PubMed ID: 27864008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Pharmacokinetic Modeling: Initial Experience in Patients With Early Arthritis.
    Maijer KI; van der Leij C; de Hair MJ; Tas SW; Maas M; Gerlag DM; Tak PP; Lavini C
    Arthritis Rheumatol; 2016 Mar; 68(3):587-96. PubMed ID: 26473331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer.
    Klawer EME; van Houdt PJ; Pos FJ; Heijmink SWTPJ; van Osch MJP; van der Heide UA
    NMR Biomed; 2018 Sep; 31(9):e3946. PubMed ID: 29974981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI: A meta-analysis.
    Gao P; Shi C; Zhao L; Zhou Q; Luo L
    Medicine (Baltimore); 2016 Dec; 95(52):e5715. PubMed ID: 28033274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic contrast-enhanced MRI perfusion parameters are imaging biomarkers for angiogenesis in lung cancer.
    Du Y; Zhang S; Liang T; Shang J; Guo C; Lian J; Gong H; Yang J; Niu G
    Acta Radiol; 2023 Feb; 64(2):572-580. PubMed ID: 35369721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perfusion of the placenta assessed using arterial spin labeling and ferumoxytol dynamic contrast enhanced magnetic resonance imaging in the rhesus macaque.
    Ludwig KD; Fain SB; Nguyen SM; Golos TG; Reeder SB; Bird IM; Shah DM; Wieben OE; Johnson KM
    Magn Reson Med; 2019 Mar; 81(3):1964-1978. PubMed ID: 30357902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic contrast enhanced MRI monitoring of primary proton and carbon ion irradiation of prostate cancer using a novel hypofractionated raster scan technique.
    Bonekamp D; Wolf MB; Edler C; Katayama S; Schlemmer HP; Herfarth K; Röthke M
    Radiother Oncol; 2016 Aug; 120(2):313-9. PubMed ID: 27237059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of different population-averaged arterial-input-functions in dynamic contrast-enhanced MRI of the prostate: Effects on pharmacokinetic parameters and their diagnostic performance.
    Othman AE; Falkner F; Kessler DE; Martirosian P; Weiss J; Kruck S; Kaufmann S; Grimm R; Kramer U; Nikolaou K; Notohamiprodjo M
    Magn Reson Imaging; 2016 May; 34(4):496-501. PubMed ID: 26708031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
    Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
    Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer.
    Vargas HA; Donati OF; Wibmer A; Goldman DA; Mulhall JP; Sala E; Hricak H
    J Sex Med; 2014 Oct; 11(10):2581-8. PubMed ID: 24754351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
    Cornud F; Beuvon F; Thévenin F; Chauveinc L; Vieillefond A; Descazeaux A; Flam T
    Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.